BL-7030

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBL-7030
Drug Alias NameEGFR-targeted synthetic dsRNA therapy (Algen)polyethylenimine-PEG-EGF-conjugated double-stranded RNA therapy (Algen)EGF-receptor-targeted poly-IC therapy (Algen)BL-7030
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hebrew University Of Jerusalem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdAlgen Biopharmaceuticals IncThe Hebrew University Of Jerusalem
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A